Showing results (461-470 of 479) with videos related to
Sort By:
Pageof 48
Journal of Gastroenterology and Hepatology|September 15, 2017
Serum cystatin C level: An excellent predictor of mortality in patients with cirrhotic ascitesYeon Seok Seo, Soo Young Park, Moon Young Kim, et al.Journal of Viral Hepatitis|May 9, 2020
Predictive score for hepatocellular carcinoma after hepatitis B e antigen loss in patients treated with entecavir or tenofovirTae Seop Lim, Hyun Woong Lee, Jung Il Lee, et al.Alimentary Pharmacology & Therapeutics|May 27, 2020
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phaseHan Ah Lee, Hyun Woong Lee, In Hee Kim, et al.Clinical and Molecular Hepatology|January 17, 2013
Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter studySe Young Jang, Go Heun Kim, Soo Young Park, et al.Journal of Hepatology|December 22, 2024
AI model using CT-based imaging biomarkers to predict hepatocellular carcinoma in patients with chronic hepatitis BHyunjae Shin, Moon Haeng Hur, Byeong Geun Song, et al.Cancers|June 10, 2023
Inverse Propensity Score-Weighted Analysis of Entecavir and Tenofovir Disoproxil Fumarate in Patients with Chronic Hepatitis B: A Large-Scale Multicenter StudyJihye Kim, Moon Haeng Hur, Seung Up Kim, et al.Small Methods|September 6, 2025
Improving HER2 Diagnostics with Digital Real-Time PCR for Ultrafast, Precise Prediction of Anti-HER2 Therapy Response in Patients with Breast CancerHee-Joo Choi, Soo Young Park, Minsik Song, et al.The Lancet. Gastroenterology & Hepatology|February 6, 2025
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trialYoung-Suk Lim, Ming-Lung Yu, Jonggi Choi, et al.Clinical and Molecular Hepatology|July 10, 2013
Efficacy and safety of entecavir plus carnitine complex (GODEX®) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL studyDae Won Jun, Byung Ik Kim, Yong Kyun Cho, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 17, 2015
Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: A multicentre, retrospective studyYeon Seok Seo, Moon Young Kim, Seung Up Kim, et al.Pageof 48